Literature DB >> 30059241

Identifying epidermal growth factor receptor mutation status in patients with lung adenocarcinoma by three-dimensional convolutional neural networks.

Jun-Feng Xiong1, Tian-Ying Jia2, Xiao-Yang Li2, Wen Yu2, Zhi-Yong Xu2, Xu-Wei Cai2, Ling Fu1, Jie Zhang3, Bin-Jie Qin1, Xiao-Long Fu2, Jun Zhao1.   

Abstract

OBJECTIVE: : Genetic phenotype plays a central role in making treatment decisions of lung adenocarcinoma, especially the tyrosine-kinase-inhibitors-sensitive mutations of the epidermal growth factor receptor (EGFR) gene. We constructed three-dimensional convolutional neural networks (CNN) to analyze underlying patterns in CT images that could indicate that EGFR gene mutation status but are invisible to human eyes.
METHODS: : From 2012 to 2015, 503 Chinese patients with lung adenocarcinoma that had underwent surgery were included. Pathological types and EGFR mutation status were tested from surgical resections. EGFR mutations (exon 19 deletion or exon 21 L858R) were found in 215/345 (62.3%) and 91/158 (57.6%) patients in the training and independent validation set, respectively. CT images were taken before any invasive operation. The patients were randomly chosen to train the CNNs or validate the CNNs' performance. The performance was quantified using area under receiver operating characteristic curve (AUC), sensitivity, specificity, and accuracy.
RESULTS: : The CNNs showed an AUC of 0.776 (range: 0.702-0.849, p< 0.0001) in the independent validation set and a fusion model of CNNs and clinical features (sex and smoking history) showed an AUC of 0.838 (range: 0.778-0.899, p< 0.0001), accuracy of 77.2%, sensitivity of 75.8% and specificity of 79.1% at the best diagnostic decision point.
CONCLUSION: : The CNN exhibits potential ability to identify EGFR mutation status in patients with lung adenocarcinoma which might help make clinical decisions. ADVANCES IN KNOWLEDGE:: The CNN showed some diagnostic power and its performance could be further improved by increasing the training set, optimizing the network structure and training strategy. Medical image based CNN has the potential to reflect spatial heterogeneity.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30059241      PMCID: PMC6319832          DOI: 10.1259/bjr.20180334

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  10 in total

1.  Predictive models for patients with lung carcinomas to identify EGFR mutation status via an artificial neural network based on multiple clinical information.

Authors:  Xiaoyi Qin; Hailong Wang; Xiang Hu; Xiaolong Gu; Wei Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2019-12-05       Impact factor: 4.553

2.  A random forest algorithm predicting model combining intraoperative frozen section analysis and clinical features guides surgical strategy for peripheral solitary pulmonary nodules.

Authors:  Liqiang Qian; Yinjie Zhou; Wanqin Zeng; Xiaoke Chen; Zhengping Ding; Yujia Shen; Yifeng Qian; Davide Tosi; Mario Silva; Yuchen Han; Xiaolong Fu
Journal:  Transl Lung Cancer Res       Date:  2022-06

3.  MLW-gcForest: a multi-weighted gcForest model towards the staging of lung adenocarcinoma based on multi-modal genetic data.

Authors:  Yunyun Dong; Wenkai Yang; Jiawen Wang; Juanjuan Zhao; Yan Qiang; Zijuan Zhao; Ntikurako Guy Fernand Kazihise; Yanfen Cui; Xiaotong Yang; Siyuan Liu
Journal:  BMC Bioinformatics       Date:  2019-11-14       Impact factor: 3.169

4.  Three-Dimensional Convolutional Neural Network-Based Prediction of Epidermal Growth Factor Receptor Expression Status in Patients With Non-Small Cell Lung Cancer.

Authors:  Xuemei Huang; Yingli Sun; Mingyu Tan; Weiling Ma; Pan Gao; Lin Qi; Jinjuan Lu; Yuling Yang; Kun Wang; Wufei Chen; Liang Jin; Kaiming Kuang; Shaofeng Duan; Ming Li
Journal:  Front Oncol       Date:  2022-02-02       Impact factor: 6.244

5.  Deep Learning to Predict EGFR Mutation and PD-L1 Expression Status in Non-Small-Cell Lung Cancer on Computed Tomography Images.

Authors:  Chengdi Wang; Xiuyuan Xu; Jun Shao; Kai Zhou; Kefu Zhao; Yanqi He; Jingwei Li; Jixiang Guo; Zhang Yi; Weimin Li
Journal:  J Oncol       Date:  2021-12-31       Impact factor: 4.375

6.  Deep learning analysis to predict EGFR mutation status in lung adenocarcinoma manifesting as pure ground-glass opacity nodules on CT.

Authors:  Hyun Jung Yoon; Jieun Choi; Eunjin Kim; Sang-Won Um; Noeul Kang; Wook Kim; Geena Kim; Hyunjin Park; Ho Yun Lee
Journal:  Front Oncol       Date:  2022-09-02       Impact factor: 5.738

7.  Implementation strategy of a CNN model affects the performance of CT assessment of EGFR mutation status in lung cancer patients.

Authors:  Junfeng Xiong; Xiaoyang Li; Lin Lu; Schwartz H Lawrence; Xiaolong Fu; Jun Zhao; Binsheng Zhao
Journal:  IEEE Access       Date:  2019-05-13       Impact factor: 3.367

Review 8.  Artificial intelligence and hybrid imaging: the best match for personalized medicine in oncology.

Authors:  Martina Sollini; Francesco Bartoli; Andrea Marciano; Roberta Zanca; Riemer H J A Slart; Paola A Erba
Journal:  Eur J Hybrid Imaging       Date:  2020-12-09

9.  Multi-channel multi-task deep learning for predicting EGFR and KRAS mutations of non-small cell lung cancer on CT images.

Authors:  Yunyun Dong; Lina Hou; Wenkai Yang; Jiahao Han; Jiawen Wang; Yan Qiang; Juanjuan Zhao; Jiaxin Hou; Kai Song; Yulan Ma; Ntikurako Guy Fernand Kazihise; Yanfen Cui; Xiaotang Yang
Journal:  Quant Imaging Med Surg       Date:  2021-06

10.  Predicting Tyrosine Kinase Inhibitor Treatment Response in Stage IV Lung Adenocarcinoma Patients With EGFR Mutation Using Model-Based Deep Transfer Learning.

Authors:  Runping Hou; Xiaoyang Li; Junfeng Xiong; Tianle Shen; Wen Yu; Lawrence H Schwartz; Binsheng Zhao; Jun Zhao; Xiaolong Fu
Journal:  Front Oncol       Date:  2021-07-20       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.